DekaBank Deutsche Girozentrale lowered its stake in CME Group Inc. (NASDAQ:CME - Free Report) by 0.5% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 682,513 shares of the financial services provider's stock after selling 3,460 shares during the quarter. DekaBank Deutsche Girozentrale owned 0.19% of CME Group worth $177,980,000 at the end of the most recent reporting period.
Several other hedge funds also recently modified their holdings of CME. Bank Pictet & Cie Europe AG increased its stake in CME Group by 29.0% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 86,941 shares of the financial services provider's stock valued at $20,190,000 after purchasing an additional 19,533 shares in the last quarter. Proficio Capital Partners LLC purchased a new position in CME Group during the 4th quarter worth $268,000. E Fund Management Co. Ltd. purchased a new position in CME Group during the 4th quarter worth $207,000. PNC Financial Services Group Inc. boosted its holdings in CME Group by 1.9% during the 4th quarter. PNC Financial Services Group Inc. now owns 155,763 shares of the financial services provider's stock worth $36,173,000 after acquiring an additional 2,974 shares during the last quarter. Finally, Larson Financial Group LLC boosted its holdings in CME Group by 22.6% during the 4th quarter. Larson Financial Group LLC now owns 2,845 shares of the financial services provider's stock worth $661,000 after acquiring an additional 525 shares during the last quarter. Institutional investors own 87.75% of the company's stock.
Analyst Upgrades and Downgrades
A number of brokerages recently weighed in on CME. JPMorgan Chase & Co. cut their price target on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating on the stock in a report on Thursday, April 24th. Wall Street Zen raised shares of CME Group from a "sell" rating to a "hold" rating in a report on Saturday. Bank of America boosted their price target on shares of CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a report on Wednesday, April 2nd. Erste Group Bank downgraded shares of CME Group from a "strong-buy" rating to a "hold" rating in a report on Saturday, May 24th. Finally, Raymond James Financial raised shares of CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price target on the stock in a report on Monday, March 10th. Three analysts have rated the stock with a sell rating, nine have issued a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat.com, CME Group presently has a consensus rating of "Hold" and a consensus target price of $259.87.
Check Out Our Latest Report on CME
CME Group Stock Down 2.4%
NASDAQ:CME traded down $6.92 during trading hours on Tuesday, hitting $275.63. The company's stock had a trading volume of 3,437,292 shares, compared to its average volume of 2,194,552. The stock has a market capitalization of $99.33 billion, a P/E ratio of 27.73, a price-to-earnings-growth ratio of 3.75 and a beta of 0.44. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The stock has a fifty day moving average of $276.69 and a 200-day moving average of $258.49. CME Group Inc. has a 52-week low of $193.17 and a 52-week high of $290.79.
CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, topping the consensus estimate of $2.61 by $0.19. CME Group had a net margin of 57.71% and a return on equity of 14.03%. The firm had revenue of $1.64 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same period last year, the business earned $2.50 EPS. CME Group's revenue for the quarter was up 10.4% compared to the same quarter last year. On average, equities analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current year.
CME Group Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th were given a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 1.81%. The ex-dividend date was Monday, June 9th. CME Group's payout ratio is 50.30%.
Insider Transactions at CME Group
In other CME Group news, Director Dennis Suskind sold 1,000 shares of the stock in a transaction that occurred on Tuesday, April 29th. The shares were sold at an average price of $271.28, for a total value of $271,280.00. Following the completion of the sale, the director owned 2,915 shares of the company's stock, valued at $790,781.20. This trade represents a 25.54% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Phyllis M. Lockett sold 1,060 shares of the business's stock in a transaction on Monday, May 19th. The stock was sold at an average price of $277.88, for a total transaction of $294,552.80. Following the transaction, the director directly owned 3,108 shares in the company, valued at approximately $863,651.04. The trade was a 25.43% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 13,400 shares of company stock valued at $3,680,610 in the last three months. Insiders own 0.30% of the company's stock.
About CME Group
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Articles

Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.